| scholarly article | Q13442814 |
| P50 | author | Li Zhang | Q71036670 |
| P2093 | author name string | Yong Zhang | |
| Xuelian Li | |||
| Baofeng Yang | |||
| Benzhi Cai | |||
| Hongli Shan | |||
| Yanjie Lu | |||
| Baoxin Li | |||
| Zhenwei Pan | |||
| Guofen Qiao | |||
| Wenfeng Chu | |||
| Chaoqian Xu | |||
| P2860 | cites work | Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions | Q21203068 |
| MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling | Q24534497 | ||
| Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals | Q24630840 | ||
| The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
| The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes | Q28241840 | ||
| Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins | Q28250776 | ||
| MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy | Q28265961 | ||
| The diverse functions of microRNAs in animal development and disease | Q28266193 | ||
| Cardiovascular effects of Danshen | Q28293119 | ||
| Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
| The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 | Q28295943 | ||
| Restricted inactivation of serum response factor to the cardiovascular system | Q28512435 | ||
| Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
| Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis | Q33315191 | ||
| Cardiac ionic currents and acute ischemia: from channels to arrhythmias | Q33676912 | ||
| Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. | Q34304925 | ||
| The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis | Q34413683 | ||
| Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation | Q34413793 | ||
| Myogenic factors that regulate expression of muscle-specific microRNAs | Q34531532 | ||
| Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions | Q34620520 | ||
| Antiarrhythmic drug research | Q35566609 | ||
| MicroRNAs in muscle differentiation: lessons from Drosophila and beyond. | Q36571084 | ||
| Serum response factor micromanaging cardiogenesis | Q37006274 | ||
| Emerging role of microRNAs in cardiovascular biology. | Q37026583 | ||
| The emerging role of microRNAs in cardiac remodeling and heart failure | Q37319218 | ||
| MicroRNAs play an essential role in the development of cardiac hypertrophy | Q39340872 | ||
| Quinidine | Q41670827 | ||
| Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation | Q42165902 | ||
| Role of the Small GTPase Rho in Modulation of the Inwardly Rectifying Potassium Channel Kir2.1 | Q42450382 | ||
| Guide to Receptors and Channels (GRAC), 3rd edition | Q43088119 | ||
| Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes | Q44961916 | ||
| Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels | Q46523785 | ||
| Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors | Q46815124 | ||
| Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms | Q46889421 | ||
| K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. | Q46954153 | ||
| Decreases of voltage-dependent K+ currents densities in ventricular myocytes of guinea pigs by chronic oxidant stress. | Q47415535 | ||
| Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA. | Q48943763 | ||
| Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia | Q68061250 | ||
| Artemisinin blocks activating and slowly activating K+ current in guinea pig ventricular myocytes | Q77902021 | ||
| Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway | Q79862172 | ||
| The changes of potassium currents in rabbit ventricle with healed myocardial infarction | Q80462574 | ||
| Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes | Q82860026 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart arrhythmia | Q189331 |
| microRNA | Q310899 | ||
| P304 | page(s) | 1227-35 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1 | |
| P478 | volume | 158 |
| Q36342169 | Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China |
| Q37511368 | Atrial fibrillation and microRNAs |
| Q92617273 | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
| Q37294594 | Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators |
| Q34011512 | Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling |
| Q31120462 | Distinctive profile of IsomiR expression and novel microRNAs in rat heart left ventricle |
| Q27308514 | Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation |
| Q37313205 | Effect of tanshinone IIA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats |
| Q41081314 | Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial |
| Q40088003 | Functional prediction of miR-3144-5p in human cardiac myocytes based on transcriptome sequencing and bioinformatics |
| Q36025533 | Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction |
| Q31812546 | Inhibition of microRNA-1 attenuates hypoxia/re-oxygenation-induced apoptosis of cardiomyocytes by directly targeting Bcl-2 but not GADD45Beta |
| Q35902471 | Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. |
| Q58767620 | Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1 |
| Q42945928 | Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy |
| Q35529032 | MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network |
| Q37032464 | MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma |
| Q38404768 | MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker |
| Q37807195 | MicroRNAs and atrial fibrillation: new fundamentals |
| Q37766210 | MicroRNAs in cardiovascular diseases: biology and potential clinical applications |
| Q38778876 | Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology |
| Q32872245 | Multifaceted roles of miR-1s in repressing the fetal gene program in the heart |
| Q34725179 | Overexpression of microRNA-1 causes atrioventricular block in rodents |
| Q54304118 | Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly. |
| Q33962144 | Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway |
| Q52561276 | Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics. |
| Q26995349 | Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death |
| Q50939526 | Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes. |
| Q55078854 | Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction. |
| Q47162432 | Soluble epoxide hydrolase inhibitors, t-AUCB, regulated microRNA-1 and its target genes in myocardial infarction mice |
| Q35885236 | Sulfotanshinone sodium injection for unstable angina pectoris: a systematic review of randomized controlled trials |
| Q42759637 | Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes |
| Q24616719 | Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway |
| Q35796569 | Tanshinone IIA: A Promising Natural Cardioprotective Agent |
| Q38055220 | Tanshinone derivatives: a patent review (January 2006 - September 2012). |
| Q33604007 | The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms |
| Q54257098 | The Role of Casein Kinase 2 in Ion Channel Remodeling After Myocardial Infarction. Editorial to: "Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2" by Xinran Li et al. |
| Q34486554 | The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model |
| Q38670411 | The regulatory function of microRNA-1 in arrhythmias |
| Q35908017 | Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2. |
| Q38110520 | miRNA in the regulation of ion channel/transporter expression |
| Q38629524 | microRNA expression changes after atrial fibrillation catheter ablation |
Search more.